VISITAG SURPOINT External Processing Unit D160801
VISITAG SURPOINT External Processing Unit D160801 is a cardiac mapping system computer (FDA Class III; FDA product code OAD, catheter, percutaneous, cardiac ablation, for treatment of atrial flutter) made by Biosense Webster Inc, approved under FDA PMA P030031 on 5 Nov 2004 and listed in FDA GUDID since 18 Jul 2018 (UDI-DI 10846835017885), active as of 23 Oct 2026. One FDA recall is linked to it.
Active
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number10846835017885 | Date18 Jul 2018 | StatusListed |
| United States | FDA PMAAPPR | NumberP030031 | Date5 Nov 2004 | StatusActive |
Official records
- AccessGUDID record 10846835017885
- FDA PMA database P030031
From the FDA record
- Device description
- External Processing Unit
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA PMA P030031 decided 5 Nov 2004 Active
- FDA GUDID UDI-DI 10846835017885 listed 18 Jul 2018 Listed
Recalls
-
- Ongoing Z-0169-2023
Manufacturing error resulted in potential contamination of Bi-Directional navigation catheter irrigation path with cellulose fibers that can cause 1) Failure of initial flushing inspection, 2) Insufficient irrigation causing catheter tip temperature increase, limiting the ability to deliver ablation, or 3) particles flushed through the catheter irrigation may have thrombogenic/toxic effect.
-
- Terminated Z-0139-2015
The recall was initiated because Biosense Webster is providing additional labeling for the safe and effective use of the ThermoCool SmartTouch Catheter.
-
- Terminated Z-0981-2012
- Terminated Z-0983-2012
- Terminated Z-0980-2012
- Terminated Z-0982-2012
- Terminated Z-0979-2012
Biosense Webster, Inc. has recently become aware of the omission of the following two Warning and Precaution statements on the Instructions For Use (IFU) for the above catheter: 1. If phrenic nerve location is a concern, precautionary measures are recommended to evaluate the proximity of the nerve to the ablation electrode, such as pacing maneuvers. 2. To minimize risk of atrio-esophageal fist
-
- Terminated Z-0057-06
Increased complaints regarding catheters with leaks and flow obstruction.
Timeline
- Approved FDA PMA P030031
- Recall initiated FDA recalls Z-0057-06
- Recall initiated FDA recalls Z-0981-2012
- Recall initiated FDA recalls Z-0983-2012
- Recall initiated FDA recalls Z-0980-2012
- Recall initiated FDA recalls Z-0982-2012
- Recall initiated FDA recalls Z-0979-2012
- Recall initiated FDA recalls Z-0139-2015
- Listed FDA GUDID 10846835017885
- Recall initiated FDA recalls Z-0169-2023
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade name
- VISITAG SURPOINT External Processing Unit
- Generic name
- Cardiac mapping system computer
- Model / Ref / Catalog
- D160801
- Primary DI / UDI-DI
- 10846835017885
- PMA number
- FDA product code
- OAD
- GMDN term
- Cardiac mapping system computer
- Device class
- Class III
- GUDID distribution status
- In Commercial Distribution